Results
|
|
3001.
|
|
|
|
3002.
|
|
|
|
3003.
|
|
|
|
3004.
|
|
|
|
3005.
|
Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. [electronic resource] by
- Chang, Katherine
- Svabek, Catherine
- Vazquez-Guillamet, Cristina
- Sato, Bryan
- Rasche, David
- Wilson, Strother
- Robbins, Paul
- Ulbrandt, Nancy
- Suzich, JoAnn
- Green, Jonathan
- Patera, Andriani C
- Blair, Wade
- Krishnan, Subramaniam
- Hotchkiss, Richard
Producer: 20150910
In:
Critical care (London, England) vol. 18
Availability: No items available.
|
|
|
3006.
|
|
|
|
3007.
|
|
|
|
3008.
|
PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementation. [electronic resource] by
- Cree, Ian A
- Booton, Richard
- Cane, Paul
- Gosney, John
- Ibrahim, Merdol
- Kerr, Keith
- Lal, Rohit
- Lewanski, Conrad
- Navani, Neal
- Nicholson, Andrew G
- Nicolson, Marianne
- Summers, Yvonne
Producer: 20171019
In:
Histopathology vol. 69
Availability: No items available.
|
|
|
3009.
|
|
|
|
3010.
|
|
|
|
3011.
|
Radiotherapy Upregulates Programmed Death Ligand-1 through the Pathways Downstream of Epidermal Growth Factor Receptor in Glioma. [electronic resource] by
- Song, Xing
- Shao, Yingjie
- Jiang, Tianwei
- Ding, Yun
- Xu, Bin
- Zheng, Xiao
- Wang, Qi
- Chen, Xin
- Gu, Wendong
- Wu, Changping
- Jiang, Jingting
Producer: 20180817
In:
EBioMedicine vol. 28
Availability: No items available.
|
|
|
3012.
|
|
|
|
3013.
|
|
|
|
3014.
|
|
|
|
3015.
|
|
|
|
3016.
|
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study. [electronic resource] by
- Hsu, Chiun
- Lee, Se-Hoon
- Ejadi, Samuel
- Even, Caroline
- Cohen, Roger B
- Le Tourneau, Christophe
- Mehnert, Janice M
- Algazi, Alain
- van Brummelen, Emilie M J
- Saraf, Sanatan
- Thanigaimani, Pradeep
- Cheng, Jonathan D
- Hansen, Aaron R
Producer: 20171219
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35
Availability: No items available.
|
|
|
3017.
|
|
|
|
3018.
|
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC. [electronic resource] by
- Spigel, David R
- Chaft, Jamie E
- Gettinger, Scott
- Chao, Bo H
- Dirix, Luc
- Schmid, Peter
- Chow, Laura Q M
- Hicks, Rodney J
- Leon, Larry
- Fredrickson, Jill
- Kowanetz, Marcin
- Sandler, Alan
- Funke, Roel
- Rizvi, Naiyer A
Producer: 20190930
In:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 13
Availability: No items available.
|
|
|
3019.
|
Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1/PD-L2 expression and literature review. [electronic resource] by
- May, Jackson M
- Waddle, Mark R
- Miller, Daniel H
- Stross, William C
- Kaleem, Tasneem A
- May, Byron C
- Miller, Robert C
- Jiang, Liuyan
- Strong, Gerald W
- Trifiletti, Daniel M
- Chaichana, Kaisorn L
- Reimer, Ronald
- Tun, Han W
- Peterson, Jennifer L
Producer: 20190314
In:
Radiation oncology (London, England) vol. 13
Availability: No items available.
|
|
|
3020.
|
|